APPLIED THERAPEUTICS INC's ticker is APLT and the CUSIP is 03828A101. A total of 46 filers reported holding APPLIED THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $61,133 | +41487.1% | 47,760 | -73.7% | 0.00% | – |
| Q1 2023 | $147 | +212.8% | 181,826 | +193.5% | 0.00% | – |
| Q4 2022 | $47 | -99.9% | 61,943 | -37.7% | 0.00% | – |
| Q3 2022 | $93,000 | -72.8% | 99,481 | -72.4% | 0.00% | – |
| Q2 2022 | $342,000 | +50.0% | 360,814 | +233.8% | 0.00% | – |
| Q1 2022 | $228,000 | -79.6% | 108,096 | -13.5% | 0.00% | – |
| Q4 2021 | $1,119,000 | +465.2% | 124,961 | +947.2% | 0.00% | – |
| Q3 2021 | $198,000 | -45.5% | 11,933 | -38.3% | 0.00% | – |
| Q1 2021 | $363,000 | -80.2% | 19,334 | -76.8% | 0.00% | -100.0% |
| Q4 2020 | $1,833,000 | +170.4% | 83,293 | +155.0% | 0.00% | 0.0% |
| Q3 2020 | $678,000 | +36.4% | 32,665 | +137.4% | 0.00% | 0.0% |
| Q2 2020 | $497,000 | -83.0% | 13,761 | -84.6% | 0.00% | -85.7% |
| Q1 2020 | $2,920,000 | +913.9% | 89,324 | +239.8% | 0.01% | – |
| Q3 2019 | $288,000 | -37.8% | 26,290 | -53.2% | 0.00% | -100.0% |
| Q2 2019 | $463,000 | – | 56,235 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 734,980 | $15,258,000 | 12.50% |
| Rock Springs Capital Management LP | 991,573 | $20,585,000 | 0.52% |
| Kore Private Wealth LLC | 125,000 | $2,595,000 | 0.50% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 503,500 | $10,453,000 | 0.46% |
| EMERALD ADVISERS, LLC | 505,075 | $10,485,000 | 0.43% |
| Orbimed Advisors | 1,546,687 | $32,109,000 | 0.40% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 627,000 | $13,017,000 | 0.27% |
| Artal Group S.A. | 380,000 | $7,889,000 | 0.19% |
| Virtus ETF Advisers LLC | 7,571 | $157,000 | 0.08% |
| Alkeon Capital Management | 738,039 | $15,322,000 | 0.03% |